Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Nationaal Kanker Instituut "Kanker Moonshot Biobank"

2 oktober 2026 bijgewerkt door: National Cancer Institute (NCI)

Kanker Moonshot Biobank Onderzoeksprotocol

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Studie Overzicht

Toestand

Actief, niet wervend

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

PRIMARY OBJECTIVE:

I. To support current and future investigations into drug resistance and sensitivity and other National Cancer Institute (NCI)-sponsored cancer research initiatives through the procurement and distribution of multiple longitudinal biospecimens and associated data from a diverse group of cancer patients who are undergoing standard of care treatment at NCI Community Oncology Research Program (NCORP) sites and other National Clinical Trials Network (NCTN) sites.

SECONDARY OBJECTIVES:

I. To provide a service of value to study participants and their medical providers through the performance of molecular profiling assays on tumor samples in a Clinical Laboratory Improvement Act (CLIA)-certified laboratory and reporting of results to physicians and patients that they may opt to use in clinical management, including analysis of data for acquired resistance mechanisms.

II. To enable the development of patient-derived models such as cell lines and xenografts for cancer researchers through the provision of biospecimens from up to 20% of study participants to the NCI's Patient Derived Models Repository (PDMR), a national resource available to investigators.

III. To develop and implement robust approaches in patient and provider engagement to improve understanding of biobanking and its relationship to cancer research and increase representation of minority and underserved study participants in cancer research.

IV. To develop increased capabilities in United States (U.S.) community hospitals and clinics for contribution to cancer research through biobanking activities.

V. To enable secondary research generated from the project through deposition of data in public repositories such as Cancer Research Data Commons (CRDC), The Cancer Imaging Archive (TCIA) and database of Genotypes and Phenotypes (dbGaP) and other potential NCI databases, including clinical, radiology and pathology data with an emphasis on treatment response and outcome data.

VI. To provide residual biospecimens and associated data from the project to the cancer research community.

OUTLINE:

Patients undergo collection of tissue samples during baseline and at time of disease progression and collection of blood samples throughout the study, including at time of disease progression. Patients with hematological malignancies also undergo collection of bone marrow and cerebral spinal fluid at the same time points. Archival blood and tissue, as well as bone marrow of patients with hematological malignancies, is also collected if available. Additionally, patients may undergo computed tomography (CT), positron emission tomography (PET)/CT and/or magnetic resonance imaging (MRI) throughout the study, and may undergo paracentesis on study. Patient medical records are reviewed, and data is collected for at least 5 years.

Studietype

Observationeel

Inschrijving (Geschat)

1600

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

  • Puerto Rico
      • San Juan, Puerto Rico, 00917
        • San Juan Community Oncology Group
      • San Juan, Puerto Rico, 00927
        • Centro Comprensivo de Cancer de UPR
      • San Juan, Puerto Rico, 00936
        • San Juan City Hospital
  • Verenigde Staten
    • Alabama
      • Daphne, Alabama, Verenigde Staten, 36526
        • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
      • Fairhope, Alabama, Verenigde Staten, 36532
        • Thomas Hospital
      • Mobile, Alabama, Verenigde Staten, 36607
        • Mobile Infirmary Medical Center
      • Saraland, Alabama, Verenigde Staten, 36571
        • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland
    • Arizona
      • Kingman, Arizona, Verenigde Staten, 86401
        • Kingman Regional Medical Center
    • Arkansas
      • Fort Smith, Arkansas, Verenigde Staten, 72903
        • Mercy Hospital Fort Smith
    • California
      • Arroyo Grande, California, Verenigde Staten, 93420
        • PCR Oncology
      • Bakersfield, California, Verenigde Staten, 93301
        • AIS Cancer Center at San Joaquin Community Hospital
      • Loma Linda, California, Verenigde Staten, 92357
        • Veterans Affairs Loma Linda Healthcare System
      • Salinas, California, Verenigde Staten, 93901
        • Salinas Valley Memorial
    • Colorado
      • Brighton, Colorado, Verenigde Staten, 80601
        • Intermountain Health Platte Valley Hospital
      • Denver, Colorado, Verenigde Staten, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Golden, Colorado, Verenigde Staten, 80401
        • Lutheran Hospital - Cancer Centers of Colorado
      • Grand Junction, Colorado, Verenigde Staten, 81501
        • Saint Mary's Hospital and Regional Medical Center
      • Lafayette, Colorado, Verenigde Staten, 80026
        • Good Samaritan Hospital - Cancer Centers of Colorado
    • Connecticut
      • Hartford, Connecticut, Verenigde Staten, 06102
        • Hartford Hospital
    • Delaware
      • Dover, Delaware, Verenigde Staten, 19901
        • Bayhealth Hospital Kent Campus
      • Milford, Delaware, Verenigde Staten, 19963
        • Bayhealth Hospital Sussex Campus
    • Florida
      • Boca Raton, Florida, Verenigde Staten, 33486
        • Boca Raton Regional Hospital
      • Deerfield Beach, Florida, Verenigde Staten, 33064
        • Broward Health North
      • Fort Lauderdale, Florida, Verenigde Staten, 33316
        • Broward Health Medical Center
      • Tampa, Florida, Verenigde Staten, 33606
        • Tampa General Hospital
    • Georgia
      • Atlanta, Georgia, Verenigde Staten, 30342
        • Northside Hospital
      • Savannah, Georgia, Verenigde Staten, 31405
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
    • Illinois
      • Bloomington, Illinois, Verenigde Staten, 61704
        • Illinois CancerCare-Bloomington
      • Chicago, Illinois, Verenigde Staten, 60612
        • John H Stroger Jr Hospital of Cook County
      • Chicago, Illinois, Verenigde Staten, 60625
        • Swedish Covenant Hospital
      • Danville, Illinois, Verenigde Staten, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, Verenigde Staten, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, Verenigde Staten, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Evanston, Illinois, Verenigde Staten, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, Verenigde Staten, 61401
        • Illinois CancerCare-Galesburg
      • Glenview, Illinois, Verenigde Staten, 60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Highland Park, Illinois, Verenigde Staten, 60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Mattoon, Illinois, Verenigde Staten, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Mount Vernon, Illinois, Verenigde Staten, 62864
        • SSM Health Good Samaritan
      • Pekin, Illinois, Verenigde Staten, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Verenigde Staten, 61615
        • Illinois CancerCare-Peoria
      • Urbana, Illinois, Verenigde Staten, 61801
        • Carle Cancer Center
      • Washington, Illinois, Verenigde Staten, 61571
        • Illinois CancerCare - Washington
    • Iowa
      • Ames, Iowa, Verenigde Staten, 50010
        • McFarland Clinic - Ames
      • Bettendorf, Iowa, Verenigde Staten, 52722
        • University of Iowa Healthcare Cancer Services Quad Cities
      • Cedar Rapids, Iowa, Verenigde Staten, 52403
        • Oncology Associates at Mercy Medical Center
      • Cedar Rapids, Iowa, Verenigde Staten, 52402
        • Physicians' Clinic of Iowa PC
      • Des Moines, Iowa, Verenigde Staten, 50309
        • Iowa Methodist Medical Center
      • Des Moines, Iowa, Verenigde Staten, 50309
        • Blank Children's Hospital
      • Des Moines, Iowa, Verenigde Staten, 50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Iowa City, Iowa, Verenigde Staten, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Louisiana
      • Baton Rouge, Louisiana, Verenigde Staten, 70808
        • Our Lady of the Lake Physician Group
      • New Orleans, Louisiana, Verenigde Staten, 70118
        • Children's Hospital New Orleans
      • New Orleans, Louisiana, Verenigde Staten, 70112
        • University Medical Center New Orleans
      • Shreveport, Louisiana, Verenigde Staten, 71103
        • LSU Health Sciences Center at Shreveport
    • Maine
      • Augusta, Maine, Verenigde Staten, 04330
        • Harold Alfond Center for Cancer Care
      • Belfast, Maine, Verenigde Staten, 04915
        • MaineHealth Waldo Hospital
      • Biddeford, Maine, Verenigde Staten, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Brunswick, Maine, Verenigde Staten, 04011
        • MaineHealth Cancer Care and IV Therapy - Brunswick
      • Brunswick, Maine, Verenigde Staten, 04011
        • Mid Coast Hospital
      • Damariscotta, Maine, Verenigde Staten, 04543
        • MaineHealth LincolnHealth Hospital
      • Farmington, Maine, Verenigde Staten, 04938
        • MaineHealth Franklin Hospital
      • Lewiston, Maine, Verenigde Staten, 04240
        • Saint Mary's Regional Medical Center
      • Norway, Maine, Verenigde Staten, 04268
        • MaineHealth Stephens Hospital
      • Portland, Maine, Verenigde Staten, 04102
        • Maine Medical Partners Surgical Care
      • Portland, Maine, Verenigde Staten, 04102
        • MMP Surgical Care Casco Bay
      • Portland, Maine, Verenigde Staten, 04102
        • MaineHealth Maine Medical Center - Portland
      • Rockport, Maine, Verenigde Staten, 04856
        • Penobscot Bay Medical Center
      • Sanford, Maine, Verenigde Staten, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • Scarborough, Maine, Verenigde Staten, 04074
        • Maine Children's Cancer Program
      • Scarborough, Maine, Verenigde Staten, 04074
        • MaineHealth Maine Medical Center- Scarborough
      • South Portland, Maine, Verenigde Staten, 04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
      • South Portland, Maine, Verenigde Staten, 04106
        • MaineHealth Urology - South Portland
    • Michigan
      • Ann Arbor, Michigan, Verenigde Staten, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Brighton, Michigan, Verenigde Staten, 48114
        • Trinity Health Medical Center - Brighton
      • Canton, Michigan, Verenigde Staten, 48188
        • Trinity Health Medical Center - Canton
      • Chelsea, Michigan, Verenigde Staten, 48118
        • Chelsea Hospital
      • Grand Rapids, Michigan, Verenigde Staten, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Iron Mountain, Michigan, Verenigde Staten, 49801
        • Dickinson County Healthcare System
      • Livonia, Michigan, Verenigde Staten, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Pontiac, Michigan, Verenigde Staten, 48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
    • Missouri
      • Ballwin, Missouri, Verenigde Staten, 63011
        • Mercy Oncology and Hematology - Clayton-Clarkson
      • Joplin, Missouri, Verenigde Staten, 64804
        • Freeman Health System
      • Joplin, Missouri, Verenigde Staten, 64804
        • Mercy Hospital Joplin
      • Rolla, Missouri, Verenigde Staten, 65401
        • Mercy Clinic-Rolla-Cancer and Hematology
      • Rolla, Missouri, Verenigde Staten, 65401
        • Phelps Health Delbert Day Cancer Institute
      • Saint Joseph, Missouri, Verenigde Staten, 64506
        • Heartland Regional Medical Center
      • Springfield, Missouri, Verenigde Staten, 65807
        • CoxHealth South Hospital
      • Springfield, Missouri, Verenigde Staten, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, Verenigde Staten, 63131
        • Missouri Baptist Medical Center
      • St Louis, Missouri, Verenigde Staten, 63109
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, Verenigde Staten, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, Verenigde Staten, 63128
        • Mercy Hospital South
      • Washington, Missouri, Verenigde Staten, 63090
        • Mercy Hospital Washington
    • Montana
      • Billings, Montana, Verenigde Staten, 59102
        • Saint Vincent Frontier Cancer Center
      • Butte, Montana, Verenigde Staten, 59701
        • Saint James Community Hospital and Cancer Treatment Center
    • Nebraska
      • Grand Island, Nebraska, Verenigde Staten, 68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
    • Nevada
      • Carson City, Nevada, Verenigde Staten, 89703
        • Carson Tahoe Regional Medical Center
      • Las Vegas, Nevada, Verenigde Staten, 89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas, Nevada, Verenigde Staten, 89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, Verenigde Staten, 89144
        • Comprehensive Cancer Centers of Nevada - Town Center
      • Las Vegas, Nevada, Verenigde Staten, 89148
        • Comprehensive Cancer Centers of Nevada
      • Las Vegas, Nevada, Verenigde Staten, 89169
        • Comprehensive Cancer Centers of Nevada - Central Valley
      • Las Vegas, Nevada, Verenigde Staten, 89103
        • Hope Cancer Care of Nevada
      • Las Vegas, Nevada, Verenigde Staten, 89183
        • OptumCare Cancer Care at Fort Apache
    • New Hampshire
      • Nashua, New Hampshire, Verenigde Staten, 03060
        • Saint Joseph Hospital
    • New Jersey
      • Morristown, New Jersey, Verenigde Staten, 07960
        • Morristown Medical Center
      • Newton, New Jersey, Verenigde Staten, 07860
        • Newton Medical Center
      • Pompton, New Jersey, Verenigde Staten, 07444
        • Chilton Medical Center
      • Summit, New Jersey, Verenigde Staten, 07902
        • Overlook Hospital
    • New York
      • New York, New York, Verenigde Staten, 10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • The Bronx, New York, Verenigde Staten, 10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx, New York, Verenigde Staten, 10467
        • Children's Hospital at Montefiore
      • The Bronx, New York, Verenigde Staten, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, Verenigde Staten, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Carolina
      • Charlotte, North Carolina, Verenigde Staten, 28204
        • Novant Health Presbyterian Medical Center
      • Greenville, North Carolina, Verenigde Staten, 27834
        • East Carolina University
      • Greenville, North Carolina, Verenigde Staten, 27834
        • ECU Health Medical Center
      • Kernersville, North Carolina, Verenigde Staten, 27284
        • Novant Health Cancer Institute - Kernersville
      • Kinston, North Carolina, Verenigde Staten, 28501
        • ECU Health Oncology Kinston
      • Mount Airy, North Carolina, Verenigde Staten, 27030
        • Novant Health Cancer Institute - Mount Airy
      • Pinehurst, North Carolina, Verenigde Staten, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Thomasville, North Carolina, Verenigde Staten, 27360
        • Novant Health Cancer Institute - Thomasville
      • Washington, North Carolina, Verenigde Staten, 27889
        • Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
      • Winston-Salem, North Carolina, Verenigde Staten, 27103
        • Novant Health Forsyth Medical Center
    • Oklahoma
      • Oklahoma City, Oklahoma, Verenigde Staten, 73120
        • Mercy Hospital Oklahoma City
    • Rhode Island
      • Providence, Rhode Island, Verenigde Staten, 02908
        • Roger Williams Medical Center
    • South Carolina
      • Columbia, South Carolina, Verenigde Staten, 29203
        • Prisma Health Richland Hospital
      • Columbia, South Carolina, Verenigde Staten, 29220
        • Prisma Health Baptist Hospital
      • Gaffney, South Carolina, Verenigde Staten, 29341
        • Gibbs Cancer Center-Gaffney
      • Greenville, South Carolina, Verenigde Staten, 29605
        • Prisma Health Greenville Memorial Hospital
      • Greer, South Carolina, Verenigde Staten, 29651
        • Gibbs Cancer Center-Pelham
      • Spartanburg, South Carolina, Verenigde Staten, 29303
        • Spartanburg Medical Center
      • Union, South Carolina, Verenigde Staten, 29379
        • SMC Center for Hematology Oncology Union
    • Texas
      • San Antonio, Texas, Verenigde Staten, 78229
        • Audie L Murphy VA Hospital
    • Virginia
      • Lynchburg, Virginia, Verenigde Staten, 24501
        • Centra Alan B Pearson Regional Cancer Center
      • Richmond, Virginia, Verenigde Staten, 23235
        • VCU Massey Cancer Center at Stony Point
      • Richmond, Virginia, Verenigde Staten, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Renton, Washington, Verenigde Staten, 98055
        • Valley Medical Center
      • Yakima, Washington, Verenigde Staten, 98902
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
    • West Virginia
      • Huntington, West Virginia, Verenigde Staten, 25701
        • Edwards Comprehensive Cancer Center
      • Morgantown, West Virginia, Verenigde Staten, 26505
        • Monongalia Hospital
    • Wisconsin
      • Eau Claire, Wisconsin, Verenigde Staten, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Marshfield, Wisconsin, Verenigde Staten, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Verenigde Staten, 53215
        • Aurora Saint Luke's Medical Center
      • Minocqua, Wisconsin, Verenigde Staten, 54548
        • Marshfield Medical Center - Minocqua
      • Rice Lake, Wisconsin, Verenigde Staten, 54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point, Wisconsin, Verenigde Staten, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Weston, Wisconsin, Verenigde Staten, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, Verenigde Staten, 54494
        • Marshfield Clinic - Wisconsin Rapids Center

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

13 jaar en ouder (Kind, Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

Patients undergoing treatment for cancer types with commercially available therapies.

Beschrijving

Inclusion Criteria:

  • Is consistent with OR has been diagnosed with one of the following:

    • Colorectal cancer: stage IV

    • Non-small cell or small cell lung cancer: stage III/IV

    • Prostate cancer: metastatic prostate cancer

    • Gastric cancer, not otherwise specified (NOS): stage IV

    • Esophageal cancer, NOS: stage IV

    • Adenocarcinoma of gastroesophageal junction: stage IV

    • High grade serous ovarian cancer: stage III/IV

    • Invasive breast carcinoma: stage III/IV

    • Melanoma: stage III/IV

    • Acute myeloid leukemia

    • Multiple myeloma

      • For the purposes of this study,

        • Re-staging is allowed
        • Having more than one primary cancer is allowed, if the patient is being treated solely for one of the eligible cancers listed above

  • Patient should fit in one of the following four clinical scenarios (a-d)

    • Undergoing diagnostic workup for one of the diseases listed for which treatment will likely include a new regimen of standard of care therapy OR
    • Scheduled to begin treatment with a new regimen of standard of care therapy OR
    • Currently progressing on a regimen of standard of care therapy OR
    • Currently being treated with a regimen standard of care therapy, without evidence of progression

  • Requirements for fresh tissue biospecimen collections at enrollment:

    • For clinical scenarios a, b, and c above, freshly collected tumor tissue or bone marrow (BM) aspirate must be submitted at enrollment

      • For clinical scenarios a and b, the fresh tissue collection must be prior to starting therapy

      • For clinical scenario a, the biospecimen collection must be part of a standard of care medical procedure

      • For clinical scenarios b or c, the biospecimen collection may be part of a standard of care medical procedure OR

      • The biospecimen collection may be part of a study-specific procedure ("research only biopsy"), when the patient has a tumor amenable to image guided or direct vision biopsy and is willing and able to undergo a tumor biopsy for molecular profiling

        • Note: For research-only biopsies, the biopsy must not be associated with a significant risk of severe or major complications or death; the procedure cannot be a mediastinal, laparoscopic, open or endoscopic biopsy; nor can the procedure be a brain biopsy; nor can the patient be under the age of majority as determined by each U.S. state

  • Requirements for archival tissue:

    • For clinical scenarios a and b above, archival tissue as outlined below must be submitted IF AVAILABLE

    • For clinical scenarios c and d above, archival tissue as outlined below is REQUIRED

    • Pre-existing archival material (formalin-fixed, paraffin-embedded [FFPE] block, BM aspirate, or unstained slides) that:

      • Contains the cancer type for which the participant is enrolled, and
      • Was collected no more than 5 years prior to initiation of therapy, and
      • Contains at least a surface area of 5 mm^2 and optimal surface area of 25 mm^2 or 3-5 mL cryopreserved bone marrow aspirate to yield 200 million bone marrow mononuclear cells, and
      • Contains at least 10% tumor content. 70% tumor content is optimal, and
      • No more than 1 line of standard of care systemic therapy was administered from the date of archival material collection to the date of initiation of therapy

  • Requirements for blood collection: ALL scenarios require fresh blood collection at enrollment

    • Blood collection for clinical scenarios a, b, and c must take place within 1 week of fresh tumor specimen collection
    • Blood collection for clinical scenario d must take place within 4 weeks of enrollment, and while patient is on treatment

  • Age 13 or older

  • Any sex

  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2

  • Ability to understand and willingness to sign an informed consent document. Consent may be provided by a Legally Authorized Representative (LAR) in accordance with 45 CFR 46.102(i)

  • NCI PDMR INCLUSION CRITERIA: Patients with CRC with mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) status

  • NCI PDMR INCLUSION CRITERIA: Patients with CRC who are 40 years old or younger at time of collection irrespective of mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) status

  • NCI PDMR INCLUSION CRITERIA: Patients with BRCA that are either

    • Any race/ethnicity with hormone receptor positive (ER+PR+, ER+PR-, or ER-PR+)
    • African American with triple negative (ER-PR-HER2-)

  • NCI PDMR INCLUSION CRITERIA: Patients with lung cancer (LCA), prostate cancer (PCA), gastroesophageal cancer (GEC), ovarian cancer (OV), acute myeloid leukemia (AML), multiple myeloma (MML)

Exclusion Criteria:

  • Treated with or has already begun treatment with a non-standard of care therapeutic agent (investigational) in an interventional clinical trial

    • For the purposes of this study, past enrollment in clinical trials whereby the patient was randomized and treated with standard-of-care anti-cancer treatment (chemotherapy regimen, surgery and radiation therapy) is allowed

  • Uncontrolled intercurrent illness that in the physician's assessment would pose undue risk for biopsy

  • Use of full dose coumarin-derivative anticoagulants such as warfarin are prohibited. Patients may be switched to low molecular weight (LMW) heparin at physician discretion

    • Low molecular weight (LMW) heparin is permitted for prophylactic or therapeutic use

    • Factor X inhibitors are permitted

    • Use of anti-platelet drugs are permitted

      • Stopping the anticoagulation treatment for biopsy, bone marrow aspirate, or resection should be per site standard operating procedure (SOP)

  • NCI PDMR EXCLUSION CRITERIA: Patients with complete response

  • NCI PDMR EXCLUSION CRITERIA: Patients with invasive fungal infections

  • NCI PDMR EXCLUSION CRITERIA: Patients with active and/or uncontrolled infections or who are still recovering from an infection

    • Actively febrile patients with uncertain etiology of febrile episode
    • All antibiotics for non-prophylactic treatment of infection should be completed at least 1 week (7 days) prior to collection
    • No recurrence of fever or other symptoms related to infection for at least 1 week (7 days) following completion of antibiotics

  • NCI PDMR EXCLUSION CRITERIA: Patients with human immunodeficiency virus (HIV), active or chronic hepatitis (i.e. quantifiable hepatitis B virus [HBV]-deoxyribonucleic acid [DNA] and/or positive hepatitis B surface antigen [HbsAg], quantifiable hepatitis C virus [HCV]-ribonucleic acid [RNA]) or known history of HBV/HCV without documented resolution

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Observatiemodellen: COHORT
  • Tijdsperspectieven: PROSPECTIVE

Cohorten en interventies

Groep / Cohort
Interventie / Behandeling
Observational (biospecimen collection, chart review)

Patients undergo collection of tissue samples during baseline and at time of disease progression and collection of blood samples throughout the study, including at time of disease progression. Patients with hematological malignancies also undergo collection of bone marrow and cerebral spinal fluid at the same time points. Archival blood and tissue, as well as bone marrow of patients with hematological malignancies, is also collected if available. Additionally, patients may undergo CT, PET/CT and/or MRI throughout the study, and may undergo paracentesis on study. Patient medical records are reviewed, and data is collected for at least 5 years.
Procedure: Computed Tomography

Undergo CT

Andere namen:
  • CT
  • KAT
  • CT-scan
  • Axiale computertomografie
  • Computergestuurde axiale tomografie
  • Computergestuurde tomografie
  • tomografie
  • Geautomatiseerde axiale tomografie (procedure)
  • Computertomografie (CT)-scan
  • Diagnostische kattencan
  • Diagnostisch CAT -scanservice type
Procedure: Magnetic Resonance Imaging

Undergo MRI

Andere namen:
  • MRI
  • Magnetische resonantie
  • Magnetic Resonance Imaging-scan
  • Medische beeldvorming, magnetische resonantie / nucleaire magnetische resonantie
  • DHR
  • MR-beeldvorming
  • MRI scan
  • NMR-beeldvorming
  • NMRI
  • Nucleaire magnetische resonantie beeldvorming
  • Magnetische resonantiebeeldvorming (MRI)
  • sMRI
  • Magnetische resonantiebeeldvorming (procedure)
  • MRI's
  • Structurele MRI
Procedure: Positron Emission Tomography

Undergo PET/CT

Andere namen:
  • Medische beeldvorming, positronemissietomografie
  • HUISDIER
  • PET-scan
  • Positron Emissie Tomografie Scan
  • Positron-emissietomografie
  • PT
  • Positronemissietomografie (procedure)
Procedure: Biospecimen Collection

Undergo collection of blood, tissue, bone marrow, and cerebral spinal fluid samples

Andere namen:
  • Biologische monsterverzameling
  • Biospecimen verzameld
  • Specimenverzameling
  • Monsterverzameling
Ander: Medical Chart Review

Medical charts are reviewed and data is collected

Andere namen:
  • Grafiek review
Procedure: Paracentesis

Undergo paracentesis

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Procure, store and distribute longitudinal biospecimens and associated clinical data
Tijdsspanne: Up to 10 years

Will procure, store and distribute longitudinal biospecimens and associated clinical data for current and future cancer research in order to elucidate molecular mechanisms of sensitivity and intrinsic or acquired resistance to standard of care systemic therapies, including immunotherapy. Cases will be grouped according to patient demographics, cancer type and treatment regimen. Statistical analysis will be descriptive and will be analyzed for each Biospecimen Source Site (BSS) as well as study aggregate.
Up to 10 years
Percentage of enrolled patients by cancer type and treatment regimen overall
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Will assess the percentage of enrolled patients by cancer type and treatment regimen overall and those who contribute samples to the Drug Resistance and Sensitivity Network and other approved investigators. Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.
Until completion of biospecimen collection, up to 3 years
Percentage of minority and underserved study participants accrued
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.
Until completion of biospecimen collection, up to 3 years

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Percentage of minority and underserved study participants accrued
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.
Until completion of biospecimen collection, up to 3 years
Pan-cancer gene panel tumor next generation sequencing test
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.
Until completion of biospecimen collection, up to 3 years
Cancer Research Data Commons, The Cancer Imaging Archive and database of Genotypes and Phenotypes data contribution
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.
Until completion of biospecimen collection, up to 3 years
Percentage of enrolled patients for whom molecular profiling is attempted
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.
Until completion of biospecimen collection, up to 3 years
Percentage of enrolled patients for whom molecular profiling results are generated
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.
Until completion of biospecimen collection, up to 3 years
Percentage of enrolled patients for whom samples are obtained at each longitudinal timepoint
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.
Until completion of biospecimen collection, up to 3 years
Percentage of collected biospecimens that are delivered to the Patient Derived Models Repository
Tijdsspanne: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.
Until completion of biospecimen collection, up to 3 years

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

National Cancer Institute (NCI)

Onderzoekers

  • Hoofdonderzoeker: Lyndsay N Harris, National Cancer Institute (NCI)

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

11 november 2020

Primaire voltooiing (Geschat)

30 april 2027

Studie voltooiing (Geschat)

30 april 2027

Studieregistratiedata

Eerst ingediend

18 maart 2020

Eerst ingediend dat voldeed aan de QC-criteria

18 maart 2020

Eerst geplaatst (Werkelijk)

19 maart 2020

Updates van studierecords

Laatste update geplaatst (Werkelijk)

5 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

2 oktober 2026

Laatst geverifieerd

1 oktober 2026

Meer informatie

Termen gerelateerd aan deze studie

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • NCI-2020-00750
  • NCI-2020-00750 (Register-ID: CTRP (Clinical Trial Reporting Program))
  • 10323 (Andere identificatie: CTEP)
  • 10323 (Andere identificatie: Division of Cancer Treatment and Diagnosis)

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren